ACADIA Pharmaceuticals Inc. ACAD 1.92% stock initially jumped above $41 per share on Thursday after the FDA granted Breakthrough Designation to the company’s dementia-related psychosis drug candidate Pimavanserin. However, the stock quickly reversed direction as the market digested the news and was trading at under $39 in the early afternoon session as the market digests the news.
In addition to the FDA ruling, Acadia announced it’s initiating its Phase II trial of Pimavanserin for treatment of DRP. Piper Jaffray analyst Charles Duncan said that the market’s initial bullish reaction was the correct one.
“Yesterday’s reveal of a novel clin/reg strategy in a broad set of dementia-related psychoses, which we see as risk-reduced by previous data and trial design, enhances our conviction in ACADIA driving upside to its base case in PDP,” Duncan wrote in a Thursday note.
Acadia is also terminating its Phase II SERENE study related to Alzheimer’s agitation/aggression to focus on collecting patients for the new Phase III HARMONY study. Duncan said focusing on the HARMONY trial is the right move for the company, as positive results could result in a much larger indication than just Alzheimer’s patients.
However, Stat News biotech reporter Adam Feuerstein wasn’t thrilled with the decision to discontinue the Alzheimer’s study. He blasted both Acadia and the FDA ruling in a series of tweets on Wednesday:
Do we need any more proof that Breakthrough Therapy Designation has become a farce? Not after today’s $ACADgrant.
Oh, by the way, $ACAD is shutting down ph2 study of pimvanserin in Alzheimer’s agitation. It’s buried at bottom of PR, like data will be.
Only 12 paragraphs down! $ACAD https://twitter.com/adamfeuerstein/status/915671404552564737 …
Utter bullshit. $ACAD shutting down SERENE bc it doesn’t want negative results coming out while ph3 is running. Would make Baker Bros. sad.
Notice how “You’re short!” (or lame variants of same) is the only tired response so many Twitter bulls can muster? Intellectually vacant. https://twitter.com/racebrookstable/status/915896578719850496 …
PiperJaffray expects…
Click here to continue reading
Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common Sense. I don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!
